| # | Drug | Count |
|---|---|---|
| 0 | PANCRELIPASE | 101 |
| 1 | METFORMIN | 96 |
| 2 | METFORMIN ER 500 MG | 88 |
| 3 | METFORMIN ER 750 MG | 88 |
| 4 | ADALIMUMAB | 80 |
| 5 | ASPIRIN | 69 |
| 6 | ASPIRIN 325 MG | 68 |
| 7 | ASPIRIN 81 MG | 68 |
| 8 | SIMVASTATIN | 53 |
| 9 | AMLODIPINE | 52 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TIRATRICOL | 1 | 0.0667 |
| 1 | BENZETHONIUM CHLORIDE 0.13% | 1 | 0.0152 |
| 2 | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0143 |
| 3 | PAROMOMYCIN SULFATE | 1 | 0.0094 |
| 4 | INDIUM IN -111 PENTETREOTIDE | 1 | 0.0078 |
| 5 | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | 1 | 0.0040 |
| 6 | MIGALASTAT HYDROCHLORIDE | 2 | 0.0036 |
| 7 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 9 | 0.0031 |
| 8 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 10 | 0.0028 |
| 9 | L-ARGININE | 1 | 0.0028 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 110 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 97 |
| 2 | Corticosteroid [EPC] | 93 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 88 |
| 4 | Insulin Analog [EPC] | 87 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 81 |
| 6 | Benzodiazepine [EPC] | 70 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 69 |
| 8 | Proton Pump Inhibitor [EPC] | 67 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 64 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Provitamin D2 Compound [EPC] | 39 | 0.0013 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 4 | Ergot Derivative [EPC] | 3 | 0.0006 |
| 5 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 6 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 8 | Dietary Cholesterol Absorption Inhibitor [EPC] | 38 | 0.0004 |
| 9 | Lipid Emulsion [EPC] | 1 | 0.0004 |